Goodwin J, Green S, Moinpour C, et al. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. J Clin Oncol 2008;26:1650–1656.
21.
Stearns V, Beebe K, Iyengar M, et al. Paroxetine controlled release in the treatment of menopausal hot ﬂashes. JAMA 2003:2827–2834.
22.
Loprinzi C, Kugler J, Sloan J, et al. Venlafaxine in management of hot ﬂashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000;356:2059–2063.
23.
Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al. Citalopram and ﬂuoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005;12:18–26.
24.
Guttuso T, Kurlan R, McDermott M, et al. Gabapentin’s effects on hot ﬂashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337–345.
25.
Soares C, Joffe H, Rubens R, et al. Eszopiclone in patients with insomnia during perimenopause and early postmenopause. Obstet Gynecol 2006;108:1402–1410.
26.
North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of the North American Menopause Society. Menopause 2007;14:357–369.
27.
Handa VL, Bachus KE, Johnston WW, et al. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstet Gynecol 1994;84:215–218.
28.
Henriksson L, Stjernquist M, Boquist L, et al. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiolreleasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996;174:85– 92.
29.
Weisberg E, Ayton R, Darling G, et al. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 2005;8:83–92.
30.
Eriksen BC. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999;180:1072–1079.
31.
Hendrix S, Cochrane B, Nygaard I, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005;293:935– 948.
32.
National Osteoporosis Foundation. Fast facts on osteoporosis.
www.nof.org.2010.
33.